CytomX Therapeutics Inc.
CTMX | NASDAQ
$2.77
+$0.01 (+0.36%)
Sep 22, 2026, 10:32 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -97.9M | -59.14M | -17.37M | 28.02M | 47.98M | 41.6M | 31.87M | 13.83M | 11.09M | 16.53M | -569K | -10.18M | -36.47M | -59.57M | -88.24M | -105.69M | -104.98M | -100.04M | -83.61M | -72.08M | -64.21M | -60.64M |
Depreciation & Amortization | 979K | 1.03M | 1.38M | 1.28M | 1.57M | 1.69M | 1.77M | 1.84M | 2.84M | 3.91M | 4.04M | 5.04M | 4.24M | 4.16M | 4.17M | 4.16M | 5.01M | 5.01M | 5.08M | 4.26M | 3.44M | 2.61M |
Stock-Based Compensation | 14.85M | 9M | 6.3M | 6.71M | 7.32M | 7.77M | 7.67M | 8.34M | 7.57M | 8.06M | 8.56M | 8.58M | 10.05M | 12.16M | 13.13M | 14.1M | 14.57M | 13.5M | 13.17M | 13.04M | 9.88M | 6.45M |
Other Working Capital | 4.29M | -36.05M | -69.89M | -111.5M | -136.44M | -142.21M | -126.45M | -108.24M | -101.42M | -101.82M | -93.64M | -11.57M | -6.76M | 1.4M | 12.57M | -25.29M | -19.61M | -16.39M | -22.31M | -52.23M | -53.87M | -62.45M |
Other Non-Cash Items | 2.3M | 2.67M | 2.68M | 2.21M | 1.53M | 386K | -1.12M | -2.76M | -3.28M | -2.2M | -1.96M | -17.05M | -15.5M | -11.67M | -10.23M | -22.6M | -20.28M | -21.19M | -21.1M | 10.63M | 11.27M | 11.03M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -28.19M | -33.65M | -68.58M | -110.47M | -135.83M | -132.67M | -126.42M | -109.53M | -102.79M | -114.13M | -62.51M | -15.68M | -8.44M | 1.85M | -22.56M | -22.52M | -19.57M | -17.56M | -22.44M | -54.52M | -57.2M | 65.61M |
Operating Cash Flow | -107.96M | -80.09M | -75.59M | -72.25M | -77.43M | -81.23M | -86.23M | -88.29M | -85.8M | -91.43M | -56.04M | -35.47M | -51.07M | -60.13M | -110.79M | -140.59M | -136.44M | -130.4M | -119.03M | -105.27M | -100.24M | 25.06M |
Capital Expenditures | -74K | -101K | -220K | -99K | -245K | -314K | -310K | -496K | -486K | -907K | -840K | -756K | -1.16M | -1.05M | -1.74M | -1.8M | -1.66M | -1.36M | -1.61M | -1.81M | -2.32M | -2.24M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -618.51M | -415.52M | -192.52M | -198.09M | -190.72M | -175.28M | -155.49M | -217.57M | -298.19M | -278.24M | -424.83M | -312.97M | -220.04M | -146.59M | n/a | n/a | n/a | -99.9M | -99.9M | -110M | -254.3M | -154.4M |
Sales Maturities Of Investments | 225M | 132.5M | 133M | 168M | 178.5M | 261M | 255.5M | 315.5M | 335M | 320M | 275M | 250M | 200M | 100M | 100M | n/a | 10M | 64M | 124M | 154M | 199.01M | 194.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -393.58M | -283.12M | -59.74M | -30.19M | -12.46M | 85.41M | 99.7M | 97.43M | 36.33M | 40.85M | -150.67M | -63.72M | -21.19M | -47.65M | 98.26M | -1.8M | 8.34M | -37.26M | 22.49M | 42.19M | -57.61M | 37.85M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 183K | 183K | 183K | 183K | 244K | 244K | 244K | 244K | n/a | n/a | n/a | 7K | 7K | 7K | -107.6M | -106.58M | -106.58M | -106.58M | 1.02M |
Financial Cash Flow | 486.38M | 344.93M | 110.45M | 96.05M | 95.8M | 7.35M | 7.52M | 5.52M | 35.19M | 30.4M | 30.23M | 30.18M | 507K | 641K | 648K | 1.14M | 1.25M | 1.49M | 110.21M | 122.55M | 122.61M | 123.47M |
Net Cash Flow | -15.16M | -18.28M | -24.89M | -6.39M | 5.91M | 11.53M | 20.99M | 14.66M | -14.29M | -20.17M | -176.48M | -69.01M | -71.75M | -107.13M | -11.88M | -141.25M | -126.86M | -166.18M | 13.67M | 59.47M | -35.24M | 186.38M |
Free Cash Flow | -108.03M | -80.19M | -75.81M | -72.35M | -77.68M | -81.54M | -86.54M | -88.78M | -86.29M | -92.34M | -56.88M | -36.22M | -52.22M | -61.18M | -112.53M | -142.39M | -138.1M | -131.77M | -120.64M | -107.08M | -102.56M | 22.81M |
Adj. Free Cash Flow | -122.88M | -89.19M | -82.11M | -79.06M | -85M | -89.31M | -94.21M | -97.12M | -93.85M | -100.39M | -65.43M | -44.8M | -62.27M | -73.34M | -125.65M | -156.49M | -152.67M | -145.27M | -133.81M | -120.12M | -112.44M | 16.36M |
Maintenance CapEx | -74K | -101K | -101K | 100K | -27K | n/a | n/a | n/a | n/a | n/a | n/a | -46.47K | -456.47K | -868.47K | -1.6M | -1.56M | -1.42M | -1.12M | -1.36M | -1.36M | -1.1M | -982K |
Growth CapEx | n/a | n/a | -119K | -199K | -218K | -314K | -310K | -496K | -486K | -907K | -840K | -709.53K | -700.53K | -183.53K | -135.53K | -245K | -245K | -245K | -245K | -445K | -1.22M | -1.26M |
Owner Earnings | -108.03M | -80.19M | -75.69M | -72.15M | -77.46M | -81.23M | -86.23M | -88.29M | -85.8M | -91.43M | -56.04M | -35.51M | -51.52M | -60.99M | -112.39M | -142.14M | -137.86M | -131.52M | -120.4M | -106.63M | -101.34M | 24.07M |
Add to Watchlist
Select watchlists to add or remove CTMX